CN105722519A - 包含琉璃苣提取物的代谢性疾病的改善、预防或治疗用组合物 - Google Patents

包含琉璃苣提取物的代谢性疾病的改善、预防或治疗用组合物 Download PDF

Info

Publication number
CN105722519A
CN105722519A CN201480061856.8A CN201480061856A CN105722519A CN 105722519 A CN105722519 A CN 105722519A CN 201480061856 A CN201480061856 A CN 201480061856A CN 105722519 A CN105722519 A CN 105722519A
Authority
CN
China
Prior art keywords
present
borage
extract
fat
metabolic disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480061856.8A
Other languages
English (en)
Chinese (zh)
Inventor
金城秀
李知垣
卢俞宪
金度希
郑尹华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NATURESENSE CO Ltd
Original Assignee
NATURESENSE CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NATURESENSE CO Ltd filed Critical NATURESENSE CO Ltd
Publication of CN105722519A publication Critical patent/CN105722519A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/30Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN201480061856.8A 2013-11-12 2014-10-27 包含琉璃苣提取物的代谢性疾病的改善、预防或治疗用组合物 Pending CN105722519A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020130136877A KR101620077B1 (ko) 2013-11-12 2013-11-12 보리지 추출물을 포함하는 대사질환 개선, 예방 또는 치료용 조성물
KR10-2013-0136877 2013-11-12
PCT/KR2014/010132 WO2015072674A1 (ko) 2013-11-12 2014-10-27 보리지 추출물을 포함하는 대사질환 개선, 예방 또는 치료용 조성물

Publications (1)

Publication Number Publication Date
CN105722519A true CN105722519A (zh) 2016-06-29

Family

ID=53057579

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480061856.8A Pending CN105722519A (zh) 2013-11-12 2014-10-27 包含琉璃苣提取物的代谢性疾病的改善、预防或治疗用组合物

Country Status (4)

Country Link
JP (1) JP6220081B2 (ja)
KR (1) KR101620077B1 (ja)
CN (1) CN105722519A (ja)
WO (1) WO2015072674A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108432924A (zh) * 2018-06-08 2018-08-24 贵州玉屏展鸿茶叶有限公司 一种防治糖尿病的保健茶

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2896646A1 (en) 2012-12-27 2014-07-03 Hayashibara Co., Ltd. Skin-exterior anti-ageing composition and production method therefor
US10426806B1 (en) * 2018-06-13 2019-10-01 Muhammad Iqbal Choudhary Anti-obesity effect of Borago officinalis linn. extracts to prevent and treat metabolic disorders
KR102193317B1 (ko) * 2019-03-12 2020-12-22 주식회사 엔에스웰니스 비만 치료 및 개선용 조성물
KR102238430B1 (ko) * 2019-05-29 2021-04-09 한국식품연구원 보리잎 유래 다당 분획물을 함유하는 비만 및 대사질환의 개선, 예방 또는 치료용 조성물
KR20220037997A (ko) 2020-09-18 2022-03-25 서울대학교산학협력단 디메틸칼콘 유도체를 포함하는 대사질환 예방 또는 치료용 조성물
KR20230135001A (ko) 2022-03-15 2023-09-22 중앙대학교 산학협력단 신규한 디메틸칼콘 유도체

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776463A (en) * 1997-02-19 1998-07-07 Arginteanu; Ronit Method of reducing stress and circulatory heart disease with freeze-dried borage petal extracts
JPH11322628A (ja) * 1998-05-12 1999-11-24 Fukiya Tadashi 皮膚外用剤
KR20040052904A (ko) * 2004-05-13 2004-06-23 약초나라(주) 혈중 콜레스테롤 및 중성지방 농도 저하 기능을 가지는천연물 조성물 및 그 제품
CN101978949A (zh) * 2010-11-16 2011-02-23 王京南 γ-亚麻酸酯脂肪乳静脉注射液及其制造方法

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
(美)尼古拉斯.裴利康: "《美丽健康与长寿的7大秘密 细胞新生的奇迹》", 31 December 2010, 黑龙江科学技术出版社 *
ANWARUL HASSAN GILANI ET AL: "Pharmacological basis for the use of Borago officinalis in gastrointestinal,respiratory and cardiovascular disorders", 《JOURNAL OF ETHNOPHARMACOLOGY》 *
MARZENA PIESZAK ET AL: "Borage (Borago officinalis L.)-a valuable medicinal plant used in herbal medicine", 《HERBA POLONICA》 *
刘荣奇: "《健康排毒全典》", 31 December 2006, 北京:海潮出版社 *
李少丹: "《规范化力量训练》", 31 December 2008 *
蔡秀成等: "琉璃苣油对脂质代谢和脂质过氧化的影响", 《中国药理学通报》 *
马学毅等: "《糖尿病自我防治》", 31 December 2004, 北京:金盾出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108432924A (zh) * 2018-06-08 2018-08-24 贵州玉屏展鸿茶叶有限公司 一种防治糖尿病的保健茶

Also Published As

Publication number Publication date
KR101620077B1 (ko) 2016-05-12
KR20150054439A (ko) 2015-05-20
WO2015072674A1 (ko) 2015-05-21
JP2016537422A (ja) 2016-12-01
JP6220081B2 (ja) 2017-10-25

Similar Documents

Publication Publication Date Title
CN105722519A (zh) 包含琉璃苣提取物的代谢性疾病的改善、预防或治疗用组合物
JP2021501119A (ja) 丹参抽出物を含む内臓脂肪型肥満予防、改善又は治療組成物
CN114096657A (zh) 新的普氏粪杆菌菌株eb-fpdk11及其用途
KR102409079B1 (ko) 오미자 추출물을 유효성분으로 함유하는 비만 예방 및 치료용 조성물
KR101501233B1 (ko) 흑차 에탄올 수용액 냉침 추출물을 함유하는 체중 및 체지방 감소 또는 지질관련 대사성 질환의 예방 또는 개선용 약학적 조성물 및 건강식품
KR20120112137A (ko) 오미자 에틸아세테이트 분획물 또는 이로부터 분리한 우웨이지수 c를 유효성분으로 포함하는 비만 예방 또는 치료용 조성물
JP5819209B2 (ja) 幹細胞から褐色脂肪細胞への分化促進剤
CN104055947A (zh) 一种含有葡萄提取物的中药组合物及制备方法
KR101732483B1 (ko) 연교 추출물을 유효성분으로 함유하는 말초신경병증 예방, 개선 또는 치료용 조성물
WO2018074831A1 (ko) 상지 주정 추출물을 함유하는 비만을 예방 또는 치료하기 위한 조성물
US10183048B2 (en) Composition for promoting the activity of peroxisome proliferator-activated receptor-delta
KR20200012363A (ko) 어수리 지하부 및 사상자 혼합 추출물을 유효성분으로 포함하는 비만의 예방, 개선 또는 치료용 조성물
KR101851639B1 (ko) 모과 추출물 또는 이의 분획물을 유효성분으로 함유하는 항비만용 조성물
CN108404088B (zh) 一种治疗ⅱ型糖尿病的中药及其制备方法
EP3750546A1 (en) Glycerol release promoter
KR100895500B1 (ko) 호노키올을 유효성분으로 함유하는 지방간 질환의 예방 및치료용 조성물
KR101689513B1 (ko) 백부근 추출물을 유효성분으로 함유하는 말초신경병증 예방, 개선 또는 치료용 조성물
JP6513404B2 (ja) 脂肪燃焼促進剤及び低体温改善剤
CN110404029B (zh) 一种具有降血糖功效的组合物及其制备方法和应用
JP5864003B1 (ja) 脂質蓄積抑制効果を有する新規羅漢果抽出物組成物
CN112812127B (zh) 一种c20-二萜生物碱类化合物及其制备方法和应用
KR102236685B1 (ko) 단삼 또는 작약 추출물을 유효성분으로 함유하는 지질대사질환 예방 또는 치료용 조성물
JP2017206477A (ja) 筋形成促進用組成物
KR20140100134A (ko) 필발 추출물을 함유하는 제2형 당뇨병 예방 및 치료용 조성물
JP2006213648A (ja) 脂肪細胞の脂肪蓄積阻害剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160629

WD01 Invention patent application deemed withdrawn after publication